Straits Times Index
3,292.69 +10.64 (+0.32%) Nikkei
38,405.66 +470.90 (+1.24%) Hang Seng
17,763.03 +16.12 (+0.09%) FTSE 100
8,144.13 -2.90 (-0.04%) Bitcoin USD
60,648.01 -3,083.94 (-4.84%) CMC Crypto 200
1,293.62 -45.45 (-3.39%)
Bayer Aktiengesellschaft (BAYN.DE)
| Previous close | 27.59 |
| Open | 27.60 |
| Bid | 27.38 x 28400 |
| Ask | 27.40 x 2100 |
| Day's range | 27.28 - 27.75 |
| 52-week range | 24.96 - 58.70 |
| Volume | |
| Avg. volume | 4,642,009 |
| Market cap | 26.869B |
| Beta (5Y monthly) | 0.97 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.11 (0.40%) |
| Ex-dividend date | 29 Apr 2024 |
| 1y target est | N/A |
- GuruFocus.com
Bayer AG's Dividend Analysis
Bayer AG (BAYRY) recently announced a dividend of $0.03 per share, payable on 2024-05-13, with the ex-dividend date set for 2024-04-29. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into Bayer AG's dividend performance and assess its sustainability.
- Zacks
Roche (RHHBY) Q1 Hit by Currency Headwinds, Lower COVID-19 Sales
Roche's (RHHBY) performance in first-quarter 2024 is pretty ho-hum as COVID-19-test sales continue to decline. The top line suffers due to the appreciation of the Swiss franc against most currencies.
- Fortune
Pharmaceutical giant Bayer’s manager cull will likely affect thousands of bosses—and the aspirin inventor thinks it will help its ‘brilliant’ Gen Z grads to thrive
Bayer currently has more than twelve tiers between management and its customers in some departments, and the aim of CEO Bill Anderson is to reduce that to around five or six.
